KINGCHEM (LIAONING) LIFE SCIENCE CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 32.06 CNY | -7.58% |
|
-12.33% | -28.91% |
| Apr. 24 | Kingchem Life Science Co., Ltd Approves the Cash Dividend for the Year 2023 | CI |
| Apr. 23 | Kingchem Life Science Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Sales 2022 | 717M 98.93M | Sales 2023 | 767M 106M | Capitalization | 5.43B 750M |
|---|---|---|---|---|---|
| Net income 2022 | 161M 22.22M | Net income 2023 | 174M 24.02M | EV / Sales 2022 * | - |
| Net cash position 2022 | 248M 34.19M | Net cash position 2023 | 546M 75.35M | EV / Sales 2023 | 6.37 x |
| P/E ratio 2022 * |
-
| P/E ratio 2023 |
26.1
x | Employees | 808 |
| Yield 2022 * |
-
| Yield 2023 |
1.27% | Free-Float | 30.5% |
More Fundamentals
* Assessed data
More news
| 1 day | -7.58% | ||
| 1 week | -12.33% | ||
| Current month | -13.47% | ||
| 1 month | -17.75% | ||
| 3 months | -28.85% | ||
| 6 months | -34.28% | ||
| Current year | -28.91% |
1 week
31.66
37.69
1 month
31.6642.68
Current year
31.6650.96
1 year
31.6679.29
3 years
31.6679.29
5 years
31.6679.29
10 years
31.6679.29
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-06 | 32.06 | -7.58% | 2,573,831 |
| 24-06-05 | 34.69 | -0.23% | 1,310,974 |
| 24-06-04 | 34.77 | -1.92% | 1,564,423 |
| 24-06-03 | 35.45 | -4.32% | 1,893,944 |
| 24-05-31 | 37.05 | +2.09% | 1,876,120 |
End-of-day quote Shenzhen S.E., June 05, 2024
More quotes
Kingchem Liaoning Life Science Co Ltd is a China-based company mainly engaged in the customized research and development and production of small molecule drug intermediates and small amounts of raw materials. The Company's products are mainly used in tumor, cardio cerebrovascular, diabetes, amyotrophic lateral sclerosis, Alzheimer's disease, acquired immune deficiency syndrome (AIDS), novel coronavirus and other disease treatment fields. Its product applications include pharmaceuticals, pesticides and specialty chemicals. The Company mainly conducts its business in the domestic market.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| -28.91% | 577M | |
| +43.64% | 749B | |
| +39.42% | 605B | |
| -6.58% | 351B | |
| +19.72% | 328B | |
| +8.78% | 292B | |
| +11.92% | 216B | |
| -2.62% | 214B | |
| +0.03% | 167B | |
| +6.13% | 165B |
- Stock Market
- Equities
- 301509 Stock
